Significance of expression of 14-3-3ζ protein in gastric cancer

Journal of Shanghai Jiaotong University (Medical Science)

Volumn 30, Issue 9, 2010, Pages 1129-1132

  Zhang, Ben Yan ^a   Yuan, Fei ^a   Xiao, Jia Cheng ^a   Liu, Bing Ya ^a   Jin, Xiao Long ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

14 3 3 ; Gastric cancer; Immunohistochemistory; Protein; Tissue microarray

Indexed keywords

14 3 3 ZETA PROTEIN; PROTEIN 14 3 3; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADVANCED CANCER; ARTICLE; CANCER INFILTRATION; CANCER TISSUE; EARLY CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; PAPILLARY CARCINOMA; PROTEIN EXPRESSION; SEROSA; SIGNET RING CARCINOMA; STOMACH CANCER; STOMACH MUCOSA; STOMACH MUSCLE; SUBMUCOSA; TISSUE MICROARRAY;

EID: 79955080094     PISSN: 16748115     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1674-8115.2010.09.026     Document Type: Article

References (13)

1. Fu H, Subramanian RR, Masters SC. 14-3-3 proteins: structure, function, and regulation[J]. Anna Rev Pharmacol Toxicol, 2000, 40: 617-647.
2. Konturek PC, Kontnrek SJ, Brzozowsfci T. Gastric cancer and Helicobacter pylori infection[J]. J Physiol Pharmacol, 2006, 57 (Suppl 3): 51-65.
3. Jang JS, Cho HY, Lee YJ, et al. The differential proteome profile of stomach cancer: identification of the biomarker candidates [J]. Oncol Res, 2004, 14(10): 491-499.
4. Bamberger AM, Riethdorf L, Milde-Langosch K, et al. Strongly reduced expression of the cell cycle inhibitor p27 in endometrial neoplasia[J]. Virchows Arch, 1999, 434(5); 423-428.
5. Niemantsverdriet M, Wagner K, Visser M, et al. Cellular functions of 14-3-3 zeta in apoptosis and cell adhesion emphasize its oncogenic character[J]. Oncogene, 2008, 27 (9): 1315-1319.
6. Danes CG, Wyszomierski SL, Lu J, et al. 14-3-3 zeta down-regulates p53 in mammary epithelial cells and confers luminal filling [J]. Cancer Res, 2008, 68(6); 1760-1767.
7. Mils V, Baldin V, Coubin F, et al. Specific interaction between 14-3-3 isoforms and the human GDC25B phosphatase [J]. Oncogene, 2000, 19(10): 1257-1265.
8. Kumagai A, Yakowec PS, Dunphy WG. 14-3-3 proteins act as negative regulators of the mitotic inducer Cdc25 in Xenopus egg extracts[J]. MolBiolCeU, 1998, 9(2); 345-354.
9. Bialkowska K, Zaffran Y, Meyer SC, et al. 14-3-3 zeta mediates integrin-induced activation of Cdc42 and Rac. Platelet glycoprotein Ib-IX regulates integrin-induced signaling by sequestering 14-3-3 zeta[J]. JBiolChem, 2003, 278(35); 33342-33350.
10. Fan T, Li R, Todd NW, et al. Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target [J]. Cancer Res, 2007, 67(16); 7901-7906.
11. Adachi Y, Yasuda K, Inomata M, et al. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type [J]. Cancer, 2000, 89(7): 1418-1424.
12. Wu CM, Lee YS, Wang TH, et al. Identification of differential gene expression between intestinal and diffuse gastric cancer using cDNA microarray[J]. Oncol Rep, 2006, 15(1): 57-64.
13. Kim SY, Kim JH, Lee HS, et al. Meta- and gene set analysis of stomach cancer gene expression data [J]. Mel Cells, 2007, 24(2): 200-209.